Help Prevent Harmful Medication Incidents
facbook twitter
Contact Us  |  Français
A component of the Canadian Medication Incident Reporting and Prevention System (CMIRPS).
 

SafeMedicationUse Newsletter



Health Canada Endorsed Important Safety Information on Pradax (dabigatran) and Plavix (clopidogrel)


Bookmark and Share

2011-11-08

Boehringer Ingelheim (Canada) Ltd. and Sanofi-aventis Canada Inc., in consultation with Health Canada, are alerting consumers to the risk of medication errors associated with name confusion between the anticoagulant Pradax and the antiplatelet drug Plavix.

More information is available on the Health Canada website.

Read the previous SafeMedicationUse.ca alert Beware of Potential Confusion Between Pradax and Plavix.

facbook twitter newsletters
Home | Report | Newsletter | News | Resources | About Us | Contact Us | Disclaimer | Privacy
Copyright © 2018 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved.